Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 5/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.52 |
| ▸ | GSK3A | P49840 | 2/20 | 0.52 |
| ▸ | GSK3B | P49841 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28991159 | 0.97 | PTGS1 (0.50) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| Ethylene Glycol SCHEMBL28669577 | 0.93 | PTGS1 (0.47) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| Alcohol SCHEMBL29133233 | 0.91 | GSK3A (0.55) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| 1,4-Butanediol SCHEMBL5570451 | 0.89 | PTGS1 (0.48) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| SCHEMBL1055378 | 0.84 | TSHR (0.43) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| Succinimide SCHEMBL27157818 | 0.84 | TSHR (0.43) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| SCHEMBL28667104 | 0.82 | MGLL (0.50) | PTGS1PTGS2GSK3AGSK3BCA12 | |
| SCHEMBL1103791 | 0.80 | GSK3A (0.48) | PTGS1PTGS2GSK3AGSK3BMGLL | |
| SCHEMBL2382060 | 0.80 | PTGS1 (0.53) | PTGS1PTGS2GSK3AGSK3BMGLL | |
| SCHEMBL20362146 | 0.80 | PTGS1 (0.62) | PTGS1PTGS2GSK3AGSK3BCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 862 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| CN-120005123-A | Acrylic ester block copolymer resin, photoresist, and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119823209-A | Synthesis method of cyclic peptide containing maleimide acid | 江苏金斯瑞生物科技有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119716071-A | Nanopore detection probe generated by connecting target molecules to be detected and load molecules, and preparation method and application thereof | 中国科学院化学研究所 | 2025-03-28 | — | — | CN | claimed |
| EP-4251210-B1 | MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ANBITION S R L (IT) | 2025-03-19 | — | — | EP | claimed |
| EP-4251211-B1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXIC DRUGS | ANBITION S R L (IT) | 2025-02-26 | — | — | EP | claimed |
| CN-116284766-B | Maleimide functionalized polyethyleneimine and preparation and application thereof | 华中科技大学 | 2024-12-31 | — | — | CN | claimed |
| CN-118772528-A | Polypropylene composition and polypropylene prepared from same | 国家能源投资集团有限责任公司 | 2024-10-15 | — | — | CN | claimed |
| CN-117457312-A | Magnetic molecular probe for specifically capturing metabolites from complex sample, and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2024-01-26 | — | — | CN | claimed |
| US-20240000967-A1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ANBITION S.R.L. (IT) | 2024-01-04 | — | — | US | claimed |
| EP-2315771-A2 | GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF | Sloan Kettering Institute For Cancer Research (US) | 2011-05-04 | — | — | EP | claimed |
| WO-2010006343-A2 | GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2010-01-14 | — | — | WO | claimed |
| EP-0996455-B1 | ALPHA-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF | SLOAN KETTERING INST CANCER (US) | 2009-12-16 | — | — | EP | claimed |
| CN-100570458-C | Method for manufacturing electrophoretic display device | CANON KK (JP) | 2009-12-16 | — | — | CN | claimed |
| US-20090099074-A1 | MODULATING FOOD INTAKE | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2009-04-16 | — | — | US | claimed |
| WO-2008049643-A2 | GD2 PEPTIDE MIMOTOPES FOR ANTICANCER VACCINATION | CHARITE - UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2008-05-02 | — | — | WO | claimed |
| EP-1916257-A1 | GD2 peptide mimotopes for anticancer vaccination | Charite-Universitätsmedizin Berlin (DE) | 2008-04-30 | — | — | EP | claimed |
| CN-1705907-A | Method for manufacturing electrophoretic display device | CANON KK (JP) | 2005-12-07 | — | — | CN | claimed |
| EP-0608445-A1 | 2,5-Dioxo-3-pyrroline-1-acetanilide fungicidal agents and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1994-08-03 | — | — | EP | claimed |
| US-5310937-A | 2,5-dioxo-3-pyrroline-1-acetanilide fungicidal agents and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1994-05-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099074-A1 | MODULATING FOOD INTAKE | GIPR, VIP, PTMS | PTGS1 2881/4885PTGS2 2893/4885GSK3A 4004/4885 |
| US-20240000967-A1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ALB, CD63, ENPEP | PTGS1 4141/4885PTGS2 4133/4885GSK3A 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.